Service

IMMS GmbH

Ehrenbergstr. 27 , 98693 Ilmenau
Germany

Telephone +49 361 6632531
Fax +49 361 6632501
balazs.nemeth@imms.de

This company is co-exhibitor of
DiagnostikNet-BB Netzwerk Diagnostik Berlin-Brandenburg e.V.

Trade fair hall

  • Hall 3 / G60
 Interactive Plan

Hall map

MEDICA 2016 hall map (Hall 3): stand G60

Fairground map

MEDICA 2016 fairground map: Hall 3

Our range of products

Product categories

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.07  Gene tests / molecular biological diagnostic

Gene tests / molecular biological diagnostic

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.14  Rapid tests - clinical chemistry

Rapid tests - clinical chemistry

  • 03  Diagnostics
  • 03.01  Clinical chemistry
  • 03.01.14  Rapid tests - clinical chemistry
  • 03.01.14.01  Point of care - testing systems

Point of care - testing systems

Our products

Product category: Gene tests / molecular biological diagnostic

Development and prototyping of DNA/RNA diagnostic kits

The focus of our microelectronic research and development in the field of biomedicine includes the development and production of miniaturised electronic DNA/RNA diagnostic kits. We offer biocompatible electronic sensorchip solutions with packaging tailored to the needs of the customers which may include polymer substrate as well. Our microelectronic systems enable the fast real-time detection of pathogens as well as the long-term monitoring of physiological parameters using only one energy efficient and portable device.

More Less

Product category: Point of care - testing systems

Development of biosensors

We offer integrated and multiphysical sensors as well as sensor networks enabling the low noise and low power acquisition of signals of biological origin. The integration of biosensors including for instance electrical, optical and biochemical operation principles on the same silicon chip allows synchronised real-time measurements. Due to the high resolution of sensor array structures it is furthermore possible to record the effects of several pathogens and bioanalytical environmental parameters at the same time.

More Less

Company news

Date

Topic

Download

Nov 15, 2016

IMMS harnesses for point-of-care diagnostics

Test setup with live demonstration for personalized diagnostics of cancer in Hall 3/G60.

Ilmenau, 15.11.2016. At the MEDICA 2016 IMMS is presenting its first approaches for the personalized diagnostics of cancer using a prototype device. It was developed in the three-year research project INSPECT which started in June 2016.

IMMS focusses on the integration of various sensor principles of different biological and chemical measurands into one integrated electronic device for extensive and precise diagnostics. The work is based on cost-efficient standard semiconductor manufacturing processes (CMOS) which IMMS also uses for these new diagnostic approaches.

IMMS adapts its systems to application-specific needs by means of particular functionalisation of surfaces and the use of biocompatible material. These solutions should pave the way for fast, reliable, cost-efficient and automated in-vitro diagnostics, such as early recognition of cancer.

In the INSPECT research project IMMS is developing systems for the early recognition of breast, cervical, prostate and lung cancers using semiconductor chips as well as immunological and cell-based biotechnological methods. IMMS is working on an interdisciplinary interface between biology and microelectronics for signal processing. In addition, further concepts for microelectronic-based point-of-care diagnostics and for personalized cancer immunotherapies are being investigated. IMMS is currently testing the first prototypes of the miniaturized diagnostic devices. The research partners iba Institut für Bioprozess- und Analysenmesstechnik e.V. Heiligenstadt, Senova Gesellschaft für Biowissenschaft und Technik mbH Weimar, CDA GmbH Suhl and X-FAB Semiconductor Foundries AG Erfurt are contributing to the novel solutions. IMMS is coordinating the consortium.

Funding:
The INSPECT project receives funding from the “Land” of Thüringen and the European Union (European Regional Development Fund (ERDF, German EFRE) under the reference 2015 FE 9159.

Partners:
  • CDA GmbH www.cda.de  
  • iba Institut für Bioprozess- und Analysenmesstechnik e.V. : www.iba-heiligenstadt.de
  • IMMS Institut für Mikroelektronik- und Mechatronik-Systeme gemeinnützige GmbH: www.imms.de
  • Senova Gesellschaft für Biowissenschaft und Technik mbH: www.senova.de
  • X-FAB Semiconductor Foundries AG: www.xfab.com

More Less

About us

Company details

As a strategic partner IMMS offers application-orientated preliminary research and development services for small and medium-sized industrial enterprises in the fields of microelectronics, mechatronics and system design. In the interdisciplinary field between microelectronics and life sciences we are specialised on the development of application-specific integrated circuits (ASICs) and electronic sensor components.

We offer customer-specific microsystems and sensor solutions for diagnostics, therapy and research also involving retinal and neuronal tissues and bioanalytics. Due to diverse applications and multi-physical effects in biology, biotechnology, chemistry and medicine we integrate our systems into customer’s devices such as microfluidic pumps and channels as well as individual optical sensor components.

We conduct both product developments and proof-of-concept studies in cooperation with our industrial and research partner companies.

We work closely together with our customers to find individually-made cutting-edge solutions for their life sciences applications.

Based on your system requirements and process specifications, we offer:

System development for point-of-care testing and in-vitro diagnostics
Design of front-end electronics for components from individual sensors and sensor arrays up to autonomous sensor systems
Multi-physical detection:
- Electric, amperometric, voltammetric,
  impedimetric, capacitive
, etc.
- Electrochemical (pH, pNa, …)
- Optical
Development of systems that include sensors and actuators
Surface coatings compatible with ions and biomaterials (DNA, proteins, …)
Wireless signal acquisition and transmission to keep biosystems intact
Application-specific and biocompatible packaging and encapsulation

Currently, there are 90 staff members working at our Institute, which was founded in 1995 as an associated research institute of the Ilmenau University of Technology (Thuringia, Germany). It has a section in Erfurt and its headquarters in Ilmenau.

More Less

Company data

Number of employees

50-99

Foundation

1995

Area of business
  • Electromedical equipment / Medical Technology
  • Diagnostics
  • Information and Communication Technology